ArticleBriefings in bioinformatics2025
LightCTL: lightweight contrastive TCR-pMHC specificity learning with context-aware prompt.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AI-driven neoantigen identification: a comprehensive review from somatic variant calling to T cell recognition.Journal of translational medicine · 2026Review
- Computational prediction of TCR cross-reactivity: principles, challenges and translational opportunities.Journal of translational medicine · 2026Review
- Advancing human leukocyte antigen-based cancer immunotherapy: from personalized to broad-spectrum strategies for genetically heterogeneous populations.Trends in cancer · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Identification of T cell receptor (TCR) specificities for antigens from large-scale single-cell or bulk TCR repertoire data plays a vital role in disease diagnosis and immunotherapy. In silico prediction models have emerged in recent years. However, the generalizability and transferability of current computational models remain significant hurdles in accurately predicting TCR-pMHC binding specificity, primarily due to the limited availability of experimental data and the vast diversity of TCR sequences. In this paper, we propose a lightweight contrastive TCR-pMHC learning with context-aware prompts, named LightCTL, to infer TCR-pMHC binding specificity. For each TCR and peptide-MHC sequence, we utilize a TCR encoding module and a pMHC encoding module to transform them into latent representations. Specifically, we introduce a contrastive TCR-pMHC learning paradigm to enhance the generalization ability of TCR-pMHC binding specificity prediction by learning the matching relationship between TCR-pMHC and MHC-peptide. We fuse the TCR and pMHC latent representations and employ a novel context-aware prompt module to consider the varying importance of different feature maps. Compared with existing methods, LightCTL substantially improves the accuracy of predicting TCR-pMHC binding specificity. Moreover, comparative experiments across eight independent datasets demonstrate the generalization ability of LightCTL, showing superior performance for predicting unknown TCR-pMHC pairs. Finally, we assess LightCTL's efficacy across different TCR sequence lengths and distinct unseen epitopes, as well as estimate cytomegalovirus-specific TCR diversity and clone frequency from peripheral TCR repertoire data. Overall, our findings highlight LightCTL as a versatile analytical method for advancing novel T-cell therapies and identifying novel biomarkers for disease diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.